LOTEMAX SM FDA approval date

The FDA approved LOTEMAX SM on 22 Feb 2019.

FDA approval date
22 Feb 2019

Drug identity has not yet been verified against registry records

Also recorded as LOTEPREDNOL ETABONATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-02-22DayLOTEMAX SMFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208219", "applicant_as_listed_by_fda": "BAUSCH AND LOMB INC", "brand_names": ["LOTEMAX SM"], "active_ingredients": ["LOTEPREDNOL ETABONATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190222", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026